Asia-Pacific Newborn Screening Market, By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Pediatric Clinics, Clinics), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Asia-Pacific Newborn Screening Market
The newborn screening market is expected to witness market growth at a rate of 13.75% in the forecast period of 2021 to 2028. Data Bridge Market Research report on the newborn screening market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while impacting the market’s growth.
Newborn screening basically enables the early detection, identification and management of babies at risk of having rare, but serious medical conditions or congenital disorders that can affect normal development and if left untreated, may lead to death.
The increase in occurrences of newborn diseases and the growing number of infants with birth defects contributes to the market's growth. Moreover, rising awareness towards pediatric congenital heart disease and backing of government towards newborn child health is further anticipated to propel the growth of the newborn screening market. However, the absence of proper healthcare infrastructure for newborn babies in developing countries and lack of skilled professionals in the healthcare industry are further projected to hamper the growth of the newborn screening market within the forecast period.
In addition, the innovation and advancements in technology and increase in number of pregnant women with advanced maternal age are projected to generate new opportunities for the market. On the other hand, the socio-economic hurdles in the implementation of newborn child screening, might further challenge the growth of the newborn screening market.
This newborn screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on newborn screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Newborn Screening Market Scope and Market Size
The newborn screening market is segmented on the basis of test type, product type, technology, disease type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of test type, the market is segmented into dried blood spot test, hearing screen test and critical congenital heart diseases (CCHD) test
- On the basis of product type, the market is segregated into instruments, reagents and assay kits
- On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis and DNA-based assays.
- On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others.
- On the basis of end user, the market is bifurcated into pediatric clinics, hospital and clinics.
Asia-Pacific Newborn Screening Country Level Analysis
The newborn screening market is analyzed and market size insights and trends are provided by test type, product type, technology, disease type and end user as referenced above. The countries covered in the newborn screening market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines and rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
The country section of the newborn screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The newborn screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for newborn screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the newborn screening market. The data is available for historic period 2010-2019.
Competitive Landscape and Asia-Pacific Newborn Screening Market Share Analysis
The newborn screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to newborn screening market.
The major players covered in the newborn screening market report are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danaher, Hill-Rom Services Inc., Intelligent Hearing Systems Corp., Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., Zentech Manufacturing, Inc., Henry Schein, Inc., Zimmer Biomet, KYOCERA Corporation, BiconLLC, Institut Straumann AG, Neoss Limited., Thommen Medical AG among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-